GLP-1 medications like semaglutide and tirzepatide are remarkably effective at reducing appetite and supporting significant weight loss. But that very effectiveness creates a nutritional challenge that many patients are not warned about before starting treatment: when you eat significantly less, getting adequate protein becomes harder and more important at the same time.
Of all the concerns men raise before starting testosterone replacement therapy, prostate health is consistently among the most common and most anxiety-producing. The worry typically goes something like this: testosterone feeds the prostate, so more testosterone must mean more prostate problems, and possibly prostate cancer.
Testosterone replacement therapy is typically described as a long-term treatment, and for most men with clinically low testosterone, the intention when starting is to continue indefinitely. But life changes. Circumstances shift. Some men decide they want to try stopping TRT, whether because of side effects, family planning considerations, cost, or simply a desire to see how their body functions without it.
You may have noticed that weight loss does not always come off evenly. You lose weight on the scale, but the stubborn belly fat seems to hold on longer than fat in other areas. In many cases, that persistent abdominal fullness is not just a cosmetic concern. It is visceral fat, and it behaves very differently from the fat you can pinch beneath the skin.
Tirzepatide has become one of the most discussed medications in medical weight loss following the results of the SURMOUNT clinical trials, which demonstrated average weight loss of up to 20 percent of body weight at the highest dose. For many patients, it represents a meaningful step forward in what prescription weight loss treatment can achieve.
If you are over 40 and have noticed that building or maintaining muscle has become significantly harder than it used to be, you are not imagining it. The physiological changes that make muscle development more challenging with age are real, measurable, and largely driven by declining testosterone levels.
Currently only accepting new clients from: New Mexico, Utah, Minnesota, Maryland, Virginia, Delaware, Colorado, West Virginia, Arizona, Iowa, Florida, Nevada, and Connecticut.
